What Is Dysbiosis? A Gut Imbalance With System-Wide Effects
If you deal with persistent bloating, abdominal pain, irregular bowels, or a vague sense of "never feeling right" after eating, you have a lot of company.
Digestive diseases affected an estimated 2.28 billion people worldwide in 2019 — roughly one in three people on the planet. In the U.S., 60–70 million people are affected each year. Functional gastrointestinal disorders (FGIDs) — now called Disorders of Gut–Brain Interaction, a category that includes IBS and functional dyspepsia — affect about 40% of people worldwide by Rome IV criteria. IBS alone may affect up to 20% of the U.S. population.
Yet despite how common these problems are, many people end up cycling through the same frustrating loop:
A diagnosis of "IBS," "SIBO," or "dysbiosis"
A course of antibiotics or antimicrobial herbs
A strict diet (often low-FODMAP) that helps for a while, then stalls
Symptoms that return — sometimes worse — once the intervention stops
This article is for anyone stuck in that cycle. Understanding how a holistic, system-based approach can restore resilience offers hope beyond just killing bacteria or restricting foods.
What Is Dysbiosis?
"Dysbiosis" is usually described as an imbalance of gut bacteria. That's true, but incomplete. A more accurate way to think about it:
Dysbiosis is a shift in your gut microbiome — a complex ecosystem where diversity, composition, and function drift away from a resilient, healthy state, highlighting the system's intricacy.
It isn't simply "bad bacteria taking over." It's a system that has stopped regulating itself well. In research terms, that shift usually involves some combination of:
Lower microbial diversity — fewer species, or dominance by just a few.
Loss of beneficial, SCFA-producing taxa — short-chain fatty acid producers like Faecalibacterium prausnitzii, Roseburia, and certain Clostridium clusters.
Overgrowth of pathobionts or opportunists — some Proteobacteria, Ruminococcus gnavus, certain E. coli strains.
Altered microbial metabolism — reduced SCFAs, changed bile acids, increased endotoxin/LPS.
Crucially, there is no single ''normal" microbiome. Dysbiosis is best understood as a departure from your own healthy baseline — one significant enough to impair how your body functions, highlighting its personalized aspect.
How common is it?
There's no clean "X% of gut symptoms are caused by dysbiosis" figure, but the evidence consistently shows that dysbiosis is a common feature of many GI conditions, especially functional ones:
Reviews find microbiota alterations are a common thread in FGIDs, linked to bloating, distension, flatulence, pain, and altered bowel habits.
In IBS, sequencing studies show reduced diversity, altered Firmicutes/Bacteroidetes ratios, lower beneficial taxa (Bifidobacterium, Lactobacillus), and overrepresentation of certain pathobionts — with symptom severity often tracking specific microbial signatures.
SIBO is more prevalent in IBS than in controls, and breath-test–defined SIBO is associated with bloating, pain, and diarrhea.
Dysbiosis is also implicated in IBD, H. pylori and C. difficile infections, and everyday digestive trouble.
The short version: among people with chronic or recurrent GI symptoms, some form of dysbiosis is very common — though not universal. And the relationship usually runs both ways: symptoms and dysbiosis reinforce each other through motility, barrier, immune, and metabolic pathways.
Why "Killing the Bugs" and "Cutting Foods" Fall Short
For many people with stubborn symptoms — especially those told they have SIBO or dysbiosis — the first instinct is to kill the overgrowth, whether with antibiotics (rifaximin, neomycin, metronidazole, ciprofloxacin) or antimicrobial herbs used in the same eradication mindset.
While antimicrobials like rifaximin can help, understanding their limitations and the need for addressing underlying drivers can foster trust and patience in the healing process.
They reduce microbial diversity across the board, removing beneficial taxa (E.g., Bifidobacterium and butyrate producers) alongside the targets.
They don't correct the underlying drivers — impaired motility, autonomic dysregulation, barrier dysfunction, immune and metabolic shifts, diet, stress, sleep.
When the "terrain" stays the same, the system drifts back toward its old dysbiotic configuration once the antimicrobial pressure lifts.
Repeated or broad-spectrum courses can leave lasting compositional changes and enrich resistance genes, making later rounds less effective and more destabilizing.
Antimicrobials can change the cast of characters, but they rarely reset the stage.
Where low-FODMAP fits
A low-FODMAP diet is the other common go-to for gas, bloating, and pain. The evidence is genuinely encouraging — and genuinely limited:
In IBS populations, roughly 50–75% of people report improvement on a structured low-FODMAP protocol.
A substantial minority get only partial relief, or none.
Response appears to depend partly on individual microbiome features (baseline fermentation capacity, specific taxa) — which helps explain why it works for some and not others.
Three caveats matter:
It's symptom-focused, not curative. Cutting fermentable substrate lowers gas and osmotic load, but it doesn't fix motility, barrier, immune, or autonomic drivers.
Overused, it can backfire. Strict, prolonged restriction is associated with reduced Bifidobacteria, lower butyrate, and potential increases in mucus-degrading bacteria. That's why guidelines frame it as a short elimination (2–6 weeks) followed by structured reintroduction and personalization — not a way of life.
It's not a SIBO fix. Many SIBO patients feel better on it, but it doesn't reliably normalize breath test results or correct underlying motility and autonomic issues.
Seen properly, low-FODMAP is one symptom-modulating tool inside a broader reset — not the reset itself.
Healing isn't really about killing bacteria or restricting foods. It's about rebuilding a resilient, well-regulated ecosystem that can absorb stressors without collapsing back into dysbiosis. To see why that matters, it helps to look at how far its effects actually extend.
Dysbiosis Can Have System-Wide Effects
Dysbiosis rarely stays a local problem. The microbes themselves largely remain in the gut, but the signals they generate — immune messages, metabolites, and neural input — travel throughout the body. Because those channels run in both directions, an imbalance in the gut can shift how the whole system regulates itself, often in loops that reinforce one another.
There are four main channels. The clearest way to see them is to walk through the systems they run on — and then how far they reach.
The Environment — Your Digestive Tract
This is where dysbiosis is most directly expressed. Three things tend to shift together:
Microbial balance — not just overgrowth (as in SIBO), but changes in where microbes live, which taxa dominate, and how they behave metabolically.
Digestion — reduced enzyme output or bile flow leaves more undigested substrate to ferment, feeding different microbes.
The barrier — the gut lining can become more permeable, letting through substances (LPS, bacterial fragments) that normally stay put.
Dysbiosis and a leaky barrier tend to develop together, each worsening the other. And once microbial products reach circulation, systemic inflammation and metabolic stress can further loosen tight junctions — deepening the cycle.
The Messengers — Microbial Metabolites: Gut microbes are chemical factories. They produce SCFAs, tryptophan metabolites, and bile acid derivatives that act far beyond the gut, shaping metabolism, inflammation, and tissue behavior. In dysbiosis, these profiles shift — less butyrate and more pro-inflammatory byproducts — destabilizing immune and metabolic signaling. Those systemic changes then feed back to favor still more dysbiosis.
The Regulator — Your Immune System: A large share of immune activity is coordinated in the gut, and the microbiome helps calibrate it — teaching it what to attack and what to tolerate. With dysbiosis, that calibration tilts toward more pro-inflammatory signaling, less tolerance (more false alarms), and chronic low-grade activation rather than targeted response. Systemic immune activation — from stress, infection, or chronic inflammation — then feeds back to the gut and reshapes the microbiome again. The core problem here isn't inflammation itself. It's the loss of regulation.
The Coordinator — Your Nervous System: The gut and nervous system are in constant two-way conversation, involving both the brain and the gut's own enteric nervous system. A few dynamics stand out:
The Migrating Motor Complex (MMC) — a rhythmic "housekeeping" wave that sweeps bacteria and debris through the small intestine between meals. When it falters, bacteria accumulate, setting the stage for SIBO.
Autonomic balance — chronic stress and sympathetic dominance reduce motility and digestive secretions, changing the environment in which microbes live.
Neurochemical signaling — microbes influence serotonin, GABA, and dopamine pathways, and are influenced by them in return.
The nervous system doesn't directly run the microbiome— it shapes the conditions in which the microbiome lives.
The Indicator — Your Skin and your Organs:
— The skin is often where internal shifts become visible. Acne, rosacea, and eczema have all been associated with gut imbalances — but the link is not one-to-one. These conditions reflect broader changes in immune signaling, systemic inflammation, and metabolic and oxidative stress that dysbiosis can contribute to. The skin frequently mirrors what's happening inside, though it's rarely the whole story.
— Distant Organs — Heart, Lungs, Brain, and Liver: Those same channels don't stop at the systems above; they carry the gut's signals to organs well outside the digestive tract. The evidence is stronger for some of these connections than others, and it's worth being clear about which is which.
The brain is the best-studied destination — the far end of the two-way conversation described above. Through the vagus nerve, the HPA stress axis, and microbial effects on serotonin and tryptophan metabolism, gut state has been linked to mood, stress response, and, increasingly, neurodegenerative disease.
The liver sits directly downstream of the gut's blood supply, making the anatomical connection immediate. Gut-derived metabolites and bacterial products influence liver inflammation and are heavily implicated in fatty liver disease, alongside broader effects on weight regulation and blood sugar.
The heart and blood vessels are primarily affected by metabolites and inflammation. When gut bacteria process choline and carnitine from foods like red meat and eggs, one byproduct — TMAO — has been associated with atherosclerosis, clotting, and cardiovascular events, and short-chain fatty acids appear to influence blood pressure. The association is consistent, though whether these metabolites contribute to cardiovascular disease or merely mark it is still being worked out.
The lungs are the newest area of study. Early-life gut disruption is associated with higher rates of asthma and COPD, and the proposed mechanism is a familiar one: shifts in short-chain fatty acids and immune balance tilting the airways toward inflammation. Much of this rests on animal models and observational data, so it's best read as a promising, active field rather than settled fact.
The pattern is the same in every case: a small set of shared channels — immune signals, metabolites, and neural input — carrying the state of the gut outward. Tend the ecosystem at its source, and you're influencing far more than digestion.
Where the Loop Starts: Common Drivers
Because the system runs in both directions, dysbiosis can be both a cause and a consequence of broader dysregulation. The most consistently supported triggers include:
Medications — antibiotics especially, but also PPIs, metformin, NSAIDs, opioids, antipsychotics, and chemotherapy, all of which can reduce diversity and alter function.
Diet — patterns low in fiber and high in ultra-processed foods, added sugars, and certain additives (emulsifiers, some preservatives, artificial sweeteners).
Chronic stress and poor sleep — circadian disruption alters motility, secretions, HPA-axis activity, and immune signaling.
Impaired motility — slower transit and MMC dysfunction let bacteria accumulate.
Infections, heavy alcohol use, and environmental exposures — pesticides, heavy metals, and similar insults perturb the gut environment.
In many people, several of these stack up over time. The microbiome shifts, systemic signaling changes, and the altered state then makes it harder for the microbiome to recover — the "vicious cycle" you may already sense.
SIBO and "Stubborn Dysbiosis": Why It Keeps Coming Back
For many people told they have SIBO, the bacteria are only part of the story. The same loops that drive dysbiosis also set the stage for SIBO — and for its return:
Impaired MMC and motility let bacteria accumulate in the small intestine.
Autonomic dysregulation (high sympathetic tone, low vagal tone) reduces secretions and motility, favoring stasis.
Barrier dysfunction and immune activation keep the gut pro-inflammatory and unstable.
Metabolic and bile acid shifts change the chemical environment, further selecting for dysbiotic patterns.
This is why killing bacteria often brings temporary relief but not lasting resolution. Leave the motility, autonomic, barrier, immune, and metabolic drivers untouched, and the system drifts right back.
What This Means for Treatment
Because these systems are interconnected, disruption in one reinforces disruption in others — which is why addressing dysbiosis usually means working on several fronts at once, and why a probiotic alone is rarely enough. If the stress patterns, immune environment, or nervous system dysregulation behind the problem go unaddressed, the gut struggles to hold on to any gains.
A more complete approach usually includes:
Dietary pattern change — more diverse fibers and resistant starches to feed SCFA producers, more fermented foods, fewer ultra-processed foods, sugars, and problematic additives. A short, structured low-FODMAP phase can help with symptom control, but it should be followed by reintroduction and personalization rather than used indefinitely.
Targeted microbial support — strain-specific probiotics and prebiotics where appropriate, keeping in mind that effects are person- and strain-specific.
Addressing the drivers — minimizing unnecessary antibiotics and acid-suppressing drugs, treating infections, improving sleep and circadian alignment, managing chronic stress, and reducing alcohol and toxin exposure.
Restoring motility and autonomic tone — supporting MMC function, vagal tone, and gut motility through behavioral, nutritional, and, where appropriate, prokinetic strategies.
One dimension often gets overlooked: the structural and physical side of nervous system function. Mechanical restrictions, altered breathing patterns, and pelvic or abdominal wall tension can subtly shift autonomic tone, motility, and lymphatic and vascular flow — all of which change the terrain in which the microbiome lives. In a physical or manual therapy context, addressing these neuromuscular factors can be a meaningful way to support microbial resilience, alongside diet, sleep, stress management, and targeted microbial interventions.
Fascial Counterstrain (FCS) is a manual therapy that works with the fascia, arteries, veins, and nerves surrounding the digestive organs. When these structures develop reflexive spasm or restriction in response to injury, inflammation, or chronic stress, they can impair motility, blood flow, and organ function — the same mechanisms that contribute to and perpetuate dysbiosis.
For some people, particularly those who haven't fully responded to dietary changes, probiotics, or stress management alone, FCS may address the anatomincal/structural layer of dysfunction and inflammation that those approaches don't directly address. It's not a standalone treatment for dysbiosis, but as part of a broader plan, it may help create the conditions the digestive system needs to actually respond to the other work being done.
How Healing Actually Happens
Healing here means restoring a resilient, diverse, functionally balanced microbiome — plus repairing the host's barrier and immune tone. Recent reviews highlight a few realities:
After a disturbance such as a short antibiotic course, the microbiome often returns to baseline within 1–12 months — but recovery is variable. Some taxa return slowly, or not at all, especially after repeated or broad-spectrum exposure.
Resilience depends on baseline diversity, metabolic flexibility, functional redundancy, and host factors like the mucus layer, bile acids, immune status, diet, sleep, and stress.
When restoration does happen, it tends to show up as:
Higher alpha diversity and the return of SCFA-producing taxa.
Improved barrier integrity — lower permeability, less systemic LPS.
Rebalanced immune signaling — lower chronic inflammatory tone, better Treg/Th17 balance.
Healthier metabolic output — more butyrate and propionate, better bile acid profiles, improved tryptophan metabolites.
In practice, this looks less like "eradicating bad bugs" and more like rebuilding a stable, well-regulated ecosystem — one that can weather stressors without collapsing back into dysbiosis.
The Takeaway
Dysbiosis is not just a gut issue. It's a shift in how the body regulates, communicates, and maintains balance. The microbiome is part of a larger network — one that includes digestion, immune function, nervous system regulation, and barrier integrity. When that network loses coordination, symptoms can appear in many different places.
Resources
Shen Y, et al. "Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy." MedComm, 2025. https://doi.org/10.1002/mco2.70168
Winter SE, Bäumler AJ. "Gut dysbiosis: Ecological causes and causative effects on human disease." PNAS, 2023. https://doi.org/10.1073/pnas.2316579120
Origiüela V, Lopez-Zaplana A. "Gut Microbiota: An Immersion in Dysbiosis, Associated Pathologies, and Probiotics." Microorganisms, 2025. https://doi.org/10.3390/microorganisms13051084
Cleveland Clinic. "Dysbiosis: What It Is, Symptoms, Causes, Treatment & Diet." https://my.clevelandclinic.org/health/diseases/dysbiosis
Deloose E, et al. "Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling." American Journal of Physiology, 2016. https://doi.org/10.1152/ajpgi.00212.2015
Pellegrini C, et al. "The Bidirectional Relationship Between the Gut Microbiome and Mental Health: A Comprehensive Review." PMC, 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007925/
Fascial Counterstrain — Digestive Disorders. Brian Tuckey PT. https://counterstrain.com/conditions/digestive-disorders/